Opportunistic discovery of occult disease by use of test panels in new, symptomatic primary care outpatients: Yield and cost of case finding

Clinical Chemistry

Volumn 46, Issue 8 I, 2000, Pages 1091-1098

  Takemura, Y ^a   Ishida, H ^a   Inoue, Y ^a   Kobayashi, H ^a   Beck, J R ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; PROTEIN; TRIACYLGLYCEROL; URIC ACID;

ARTICLE; BLOOD ANALYSIS; BLOOD EXAMINATION; CASE FINDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERLIPIDEMIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; OUTPATIENT; PRIMARY MEDICAL CARE; PROTEIN ANALYSIS; URINALYSIS;

EID: 0033900162     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.8.1091     Document Type: Article

References (24)

1. Essential Laboratory Tests (a proposal)
2. Common diagnostic test panels for clinical evaluation of new primary care outpatients in Japan: A cost-effectiveness evaluation
3. The effects of a fixed-fee reimbursement system introduced by the federal government on laboratory testing in the United States
4. Healthcare in the United States and the practice of laboratory medicine
5. Rationale for cost-effective laboratory medicine
6. The utility of routine chest radiographs
7. The periodic health examination: Genesis of a myth
8. Medicare coding and reimbursement for clinical laboratory services
9. The results of the 'Essential Laboratory Tests' applied to new outpatients - Re-evaluation of diagnostic efficiencies of the test items
10. Biochemical profiles: Applications in ambulatory screening and preadmission testing of adults
11. Pathogenesis-screening tests for liver dysfunction in the asymptomatic patients with elevated ALT values and their diagnostic efficiencies in primary care medicine
12. Second report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
13. Clinical guideline, part 1: Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults
14. Clinical guideline, part 2: Cholesterol screening in asymptomatic adults, revised
15. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study
16. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
17. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
18. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
19. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
20. Cholesterol lowering with statin drugs, risk of stroke, and total mortality: An overview of randomized trials
21. The cost-effectiveness of screening for type 2 diabetes
22. Utility of the routine electrocardiogram before surgery and on general hospital admission
23. A cost-effectiveness analysis of a pre-visit testing system for new outpatients in primary care medicine